Biomarcadores moleculares en enfermedad renal aguda para determinar porcentaje de daño en el parenquima: revisión bibliográfica

La enfermedad renal es una de las patologías mas densas que hay en la clínica diaria de pequeños animales y tiene variedad de etiologías, su diagnóstico es complejo y los mecanismos de tratamiento son diversos dependiendo de los diferentes porcentajes de lesión presente, lo ideal es determinar o apr...

Full description

Autores:: Gil Palma, Miguel Angel

Tipo de recurso:: Trabajo de grado de pregrado

Fecha de publicación:: 2020

Institución:: Universidad Cooperativa de Colombia

Repositorio:: Repositorio UCC

Idioma:

id	COOPER2_11147e2c176c30d9820b34e80d0aa77c
oai_identifier_str	oai:repository.ucc.edu.co:20.500.12494/16880
network_acronym_str	COOPER2
network_name_str	Repositorio UCC
repository_id_str
dc.title.spa.fl_str_mv	Biomarcadores moleculares en enfermedad renal aguda para determinar porcentaje de daño en el parenquima: revisión bibliográfica
title	Biomarcadores moleculares en enfermedad renal aguda para determinar porcentaje de daño en el parenquima: revisión bibliográfica
spellingShingle	Biomarcadores moleculares en enfermedad renal aguda para determinar porcentaje de daño en el parenquima: revisión bibliográfica Biomarcadores Enfermedad renal Caninos Felinos Diagnóstico TG 2020 MVZ 16880 Biomarkers Kidney disease Canines Felines Diagnosis
title_short	Biomarcadores moleculares en enfermedad renal aguda para determinar porcentaje de daño en el parenquima: revisión bibliográfica
title_full	Biomarcadores moleculares en enfermedad renal aguda para determinar porcentaje de daño en el parenquima: revisión bibliográfica
title_fullStr	Biomarcadores moleculares en enfermedad renal aguda para determinar porcentaje de daño en el parenquima: revisión bibliográfica
title_full_unstemmed	Biomarcadores moleculares en enfermedad renal aguda para determinar porcentaje de daño en el parenquima: revisión bibliográfica
title_sort	Biomarcadores moleculares en enfermedad renal aguda para determinar porcentaje de daño en el parenquima: revisión bibliográfica
dc.creator.fl_str_mv	Gil Palma, Miguel Angel
dc.contributor.advisor.none.fl_str_mv	Trujillo Piso, Dunia Yisela
dc.contributor.author.none.fl_str_mv	Gil Palma, Miguel Angel
dc.subject.spa.fl_str_mv	Biomarcadores Enfermedad renal Caninos Felinos Diagnóstico
topic	Biomarcadores Enfermedad renal Caninos Felinos Diagnóstico TG 2020 MVZ 16880 Biomarkers Kidney disease Canines Felines Diagnosis
dc.subject.classification.spa.fl_str_mv	TG 2020 MVZ 16880
dc.subject.other.spa.fl_str_mv	Biomarkers Kidney disease Canines Felines Diagnosis
description	La enfermedad renal es una de las patologías mas densas que hay en la clínica diaria de pequeños animales y tiene variedad de etiologías, su diagnóstico es complejo y los mecanismos de tratamiento son diversos dependiendo de los diferentes porcentajes de lesión presente, lo ideal es determinar o aproximar el porcentaje del daño y a su vez poder instaurar el tratamiento idóneo, para así lograr mantener una función renal optima y generar una calidad de vida en los pacientes y por medio de este articulo mostramos los diferentes biomarcadores y su efectividad en la determinación del daño renal y porcentaje afectado en el parénquima.
publishDate	2020
dc.date.accessioned.none.fl_str_mv	2020-02-19T20:59:24Z
dc.date.available.none.fl_str_mv	2020-02-19T20:59:24Z 2020-08-18
dc.date.issued.none.fl_str_mv	2020-02-18
dc.type.none.fl_str_mv	Trabajo de grado - Pregrado
dc.type.coar.none.fl_str_mv	http://purl.org/coar/resource_type/c_7a1f
dc.type.driver.none.fl_str_mv	info:eu-repo/semantics/bachelorThesis
dc.type.version.none.fl_str_mv	info:eu-repo/semantics/acceptedVersion
format	http://purl.org/coar/resource_type/c_7a1f
status_str	acceptedVersion
dc.identifier.uri.none.fl_str_mv	https://hdl.handle.net/20.500.12494/16880
dc.identifier.bibliographicCitation.spa.fl_str_mv	Gil Palma, M. Á. (2020). Biomarcadores moleculares en enfermedad renal aguda para determinar porcentaje de daño en el parenquima: Revisión bibliográfica. (Tesis de pregrado) Recuperado de: http://hdl.handle.net/20.500.12494/16880
url	https://hdl.handle.net/20.500.12494/16880
identifier_str_mv	Gil Palma, M. Á. (2020). Biomarcadores moleculares en enfermedad renal aguda para determinar porcentaje de daño en el parenquima: Revisión bibliográfica. (Tesis de pregrado) Recuperado de: http://hdl.handle.net/20.500.12494/16880
dc.relation.references.spa.fl_str_mv	Chew D, Dibartola S, Schenck P. Canine and feline nephrology and urology. 2nd ed. Louis S, editor. Missouri: Elsevier Inc.; 2011. Bartges J, Polzin D. Nephrology and urology of small animals. 1st ed. Lowa: Wiley-Blackwell; 2011. Elliot J, Grauer G. Manual of canine and feline nephrology and urology. 2nd ed. Quedgley: BSAVA; 2007. IRIS Grading of AKI. International renal interes society. [Online].; 2013 [cited 2019 noviembre 10. Available from: http://www.iris-kidney.com. Cobrin A. Measurement of serum and urine neutrophil gelatinase-associated lipocalin (NGAL) in dogs with chronic kidney disease, lymphosarcoma, carcinoma and induced endotoxemia to assess diagnostic utility of NGAL in dogs with chronic kidney disease. Tesis presentada de la universidad de guelph como cumplimiento parcial para el grado de doctor en ciencias veterinarias. Ontario:; 2013. Arias M, Egido J, Lamas S, Praga M, Séron D. Nefrología Clínica. 4th ed. Madrid: Medica Panamericana; 2014. Almy F. CM, King D. BS. Evaluation of cystatin c as an endogenous marke of glomerular filtration rate in dogs.. Journal of Veterinary Internal Medicine. 2002; 16. Ross L. Acute kidney injury in dogs and cats. Veterinary Clinics of North America: Small Animal Practice. 2011; 41. Ostermann M, Philips B, Forni L. Clinical review: biomarkers of acute kidney injury: where are we now. Critical Care. 2012; 16(233). De Geus H, Betjes M, Bakker J. Biomarkers for the prediction of acute kidney injury: a narrative review on current status and future challenges. Clinical Kidney Journal. 2012; 5. McDuffie JE, Gao J, Ma J, La D, Bittner A, Sonee M, et al. Novel genomic biomarkers for acute gentamicinnephrotoxicity in dog. Journal of Molecular and Integrative Physiology. 2013; 3. Bland SK, Cote O, Clark ME, DeLay J, Bienzie D. Characterization of kidney injury molecule-1 in cats. Journal of Veterinary Internal Medicine. 2014; 28. García MF, Coll E, Ventura S, Bermudo C, Cárdenas MC, Cortés M, et al. Cistatina c en evaluación de la función renal. Revista Laboratorio Clínico. 2011; 4(1). Ghys L, Paepe D, Smets P, Lefebvre H. DJ, Damiet S. Cystatin c: a new renal marker and its potential use in small animal medicine. Journal of veterinary Internal Medicine. 2014; 28. Wehner A, Hartmann K, Hirschberger J. Utility of serum cystatin c as a clinical measure of renal function in dogs. J Am Animal Hosp Assoc. 2008; 44(3). Miyagawa Y, Takemura N, Hirose H. Evaluation of the measurement of serum cystatin c by an enzyme-linked inmmunosorbent assay for humans as a marker of the glomerular filtration rate in dogs. J Vet Med Sci. 2009 septiembre; 71(76). Cobrin A, Blois SL, Kruth SA, Abrams-Ogg A CG, Dewey C. Biomarker in the assessment of acute and chronic diseases in the dog and cat. Journal of Small Animal Practice. 2013; 54. Knight E, Verhave J, Spiegelman D, Hillege H. Factors influencing serum cystatin c levels other than renal function and the impact on renal function measurement. Kidney International. 204; 65. De Loor J, Daminet S, Smets P, Maddens B, Meyer E. Urinary biomarkers for acute kidney injury in dogs. Journal of Veterinary Internal Medicine. 2013; 27. Nabity MB, Lees GE, Boggess MM, Yerramilli M, Obare E, Yerramili M, et al. Symmetric dimethylarginine assay validation, stability, and evaluation as a marker for the early dteection of chronic kidney disease in dogs. Journal of Veterinary Internal Medicine. 2015; 29(4). Raila J, Brunnberg L, Schweigert FJ, Kohn B. Influence of kidney function on urinary excretion of albumin and retinolbindig protein in dogs with naturally occurring renal disease. Am J Vet Res. 2010; 71. Hall JA, Yerramilli M, Obare E, Yerramilli M, Jewell DE. Comparison of serum concentrations of symmetric dimethylarginine and creatinine as kidney function biomarkers in cats with chronic kidney disease. Journal of Veterinary Internal Medicine. 2014; 28. Hall J, Yerramilli M, Obare E, Yerramilli M, Melendez L, Jewell D. Relationship between lean body mass and serum renal biomarkers in healthy dogs. Journal of Veterinary Internal Medicine. 2015 marzo; 29(3). Brian J, Obare E, Yerramilli M, Elliott J, Yerramilli M. Relationship between serum symmetric dimethylarginine concentrartion and glomerular filtration rate in cats. Journal of veterinary Internal Medicine. 2014; 28. Vinge L, Lees GE, Nielsen R, Kashtan CE, Bahr A. The effect of progressive glomerular disease on megalin-mediated endocytosis in kidney. Nephronl Dial Transplant. 2010; 25. Nabity MB, Lees GE, Cianciolo R, Boggess MM, Steiner JM, Suchodolski JS. Urinary biomarkers of renal disease in dogs with x-linked hereditary nephropathy. J Vet Intern Med. 2012; 26. Carrillo Esper R, Castillo Albarrán F, Pérez Jáuregui J. Lipocalina asociada con la gelatinasa de neutrófilos, un nuevo marcador de lesión renal aguda en el enfermo grave. Cirugía y Cirujanos. 2011; 79. Lee YJ, Hu YY, Lin YS, Chang CT, Lin FY, Wong ML, et al. Urine neutrophil gelatinase-associated lipocain (NGAL) as a biomarker for acute canine kidney injury. BMC Veterinary Research. 2012; 8. Steincbach S, Weis J, Schweighauser A, Francey T, Neiger R. Plasma and urine neutrophil gelatinase-associated lipocalin (NGAL) in dogs with acute kidney injury or chronic kidney. Journal of Veterinary Internal Medicine. 2014; 28. Seveg G, Palm C, LeRoy B, Cowgill LD, Westropp JL. Evaluation of neutrophil gelatinase-asscoated lipocalin as a marker of kidney injury in dogs. Journal of Veterinary Internal Medicine. 2013; 27. Bishop SA, Lucke VM, Stoke CR, Gruffydd-Jones TJ. Plasma and urine biochemical changes in cats with experimental inmune complex glomerulonephritis. Journal of Comparative Pathology. 1991; 104. Jepson RE, Brodbelt D, Vallance C, Syme HM, Elliot J. Evaluation of predictors of the development of azotemia in cats. Journal of Veterinary Internal Medicine. 2009; 23. Sparkes A, Caney S, Chalhoub S, Elliott J, Finch N, Gajanayake I, et al. ISFM Consensus Guidelines on the Diagnosis and Management of Feline Chronic Kidney Disease. Journal of Feline Medicine and Surgery. 2016; 18. Di Bartola SP. Renal Disease: Clinical Approach and Laboratory Evaluation. 6th ed. Ettinger SJ FE, editor. Saint Louis: Elsevier Saunders.; 2005. Watson AD, Lefebvre HP, Concordet D. Plasma exogenous creatinine clearance test in dogs: comparison with other methods and proposed limited sampling strategy. J Vet Inten Med. 2002; 16. Syme HM. Proteinuria in cats. Pronostic marker or mediator. J Feline Med Surg. 2009; 11. Lees GE, Jensen WA, Simpson DF. Persistent albuminuria precedes onset of overt proteinuria in male dogs with x-linked hereditary nephropathy. J Vet Intern Med. 2002; 16. Cotadellas O. Estadificación y Manejo de la enfermedad renal cronica. In Cortadella O, editor. Manual de nefrología y urología clínica canina y felina. Zaragoza: Grupo Asis Biomedia SL; 2012. p. 161-177.
dc.rights.license.none.fl_str_mv	Atribución – No comercial – Compartir igual
dc.rights.accessrights.none.fl_str_mv	info:eu-repo/semantics/closedAccess
dc.rights.coar.none.fl_str_mv	http://purl.org/coar/access_right/c_14cb
rights_invalid_str_mv	Atribución – No comercial – Compartir igual http://purl.org/coar/access_right/c_14cb
eu_rights_str_mv	closedAccess
dc.format.extent.spa.fl_str_mv	17 p.
dc.publisher.spa.fl_str_mv	Universidad Cooperativa de Colombia, Facultad de Ciencias de la Salud, Medicina Veterinaría y Zootecnia, Ibagué
dc.publisher.program.spa.fl_str_mv	Medicina veterinaria y zootecnia
dc.publisher.place.spa.fl_str_mv	Ibagué
institution	Universidad Cooperativa de Colombia
bitstream.url.fl_str_mv	https://repository.ucc.edu.co/bitstreams/0b276d68-917f-498d-98e1-bc22c0989665/download https://repository.ucc.edu.co/bitstreams/5b1e4bba-0b85-4c33-aea3-97924db13140/download https://repository.ucc.edu.co/bitstreams/7c598537-c602-43d0-bbf0-501bbacbdeca/download https://repository.ucc.edu.co/bitstreams/26b5e49f-1a4e-43a0-a8d0-32453444e655/download https://repository.ucc.edu.co/bitstreams/abee456e-35fe-414c-9bb0-2479e957b84b/download https://repository.ucc.edu.co/bitstreams/5b25b125-3b06-4f6c-8033-c2a270d253db/download https://repository.ucc.edu.co/bitstreams/fdffd3f1-5c90-4ef8-a4b2-175f261d742f/download
bitstream.checksum.fl_str_mv	3bce4f7ab09dfc588f126e1e36e98a45 065fb1b1d6400d4e5b9931233e592dd1 c315274147b94cb8acd7446d5baedb59 66638ed6ef7a876f7f555d368e9b0a31 fdc1794b698981c85bd540236fe3de90 605dc0dabf68501b5058c5afa2d7b1db ba6c6cdaf9a61e494cc62d8d1e4a5fe5
bitstream.checksumAlgorithm.fl_str_mv	MD5 MD5 MD5 MD5 MD5 MD5 MD5
repository.name.fl_str_mv	Repositorio Institucional Universidad Cooperativa de Colombia
repository.mail.fl_str_mv	bdigital@metabiblioteca.com
_version_	1814246925348634624
spelling	Trujillo Piso, Dunia YiselaGil Palma, Miguel Angel2020-02-19T20:59:24Z2020-02-19T20:59:24Z2020-08-182020-02-18https://hdl.handle.net/20.500.12494/16880Gil Palma, M. Á. (2020). Biomarcadores moleculares en enfermedad renal aguda para determinar porcentaje de daño en el parenquima: Revisión bibliográfica. (Tesis de pregrado) Recuperado de: http://hdl.handle.net/20.500.12494/16880La enfermedad renal es una de las patologías mas densas que hay en la clínica diaria de pequeños animales y tiene variedad de etiologías, su diagnóstico es complejo y los mecanismos de tratamiento son diversos dependiendo de los diferentes porcentajes de lesión presente, lo ideal es determinar o aproximar el porcentaje del daño y a su vez poder instaurar el tratamiento idóneo, para así lograr mantener una función renal optima y generar una calidad de vida en los pacientes y por medio de este articulo mostramos los diferentes biomarcadores y su efectividad en la determinación del daño renal y porcentaje afectado en el parénquima.Kidney disease is one of the densest pathologies that exist in the daily clinic of small animals and has a variety of etiologies, its diagnosis is complex and the treatment mechanisms are diverse depending on the different percentages of lesion present, the ideal is to determine or approximate the percentage of damage and in turn be able to establish the ideal treatment, in order to maintain optimal renal function and generate a quality of life in patients and through this article we show the different biomarkers and their effectiveness in determining renal damage and percentage affected in the parenchyma.miguel.gilp@campusucc.edu.co17 p.Universidad Cooperativa de Colombia, Facultad de Ciencias de la Salud, Medicina Veterinaría y Zootecnia, IbaguéMedicina veterinaria y zootecniaIbaguéBiomarcadoresEnfermedad renalCaninosFelinosDiagnósticoTG 2020 MVZ 16880BiomarkersKidney diseaseCaninesFelinesDiagnosisBiomarcadores moleculares en enfermedad renal aguda para determinar porcentaje de daño en el parenquima: revisión bibliográficaTrabajo de grado - Pregradohttp://purl.org/coar/resource_type/c_7a1finfo:eu-repo/semantics/bachelorThesisinfo:eu-repo/semantics/acceptedVersionAtribución – No comercial – Compartir igualinfo:eu-repo/semantics/closedAccesshttp://purl.org/coar/access_right/c_14cbChew D, Dibartola S, Schenck P. Canine and feline nephrology and urology. 2nd ed. Louis S, editor. Missouri: Elsevier Inc.; 2011.Bartges J, Polzin D. Nephrology and urology of small animals. 1st ed. Lowa: Wiley-Blackwell; 2011.Elliot J, Grauer G. Manual of canine and feline nephrology and urology. 2nd ed. Quedgley: BSAVA; 2007.IRIS Grading of AKI. International renal interes society. [Online].; 2013 [cited 2019 noviembre 10. Available from: http://www.iris-kidney.com.Cobrin A. Measurement of serum and urine neutrophil gelatinase-associated lipocalin (NGAL) in dogs with chronic kidney disease, lymphosarcoma, carcinoma and induced endotoxemia to assess diagnostic utility of NGAL in dogs with chronic kidney disease. Tesis presentada de la universidad de guelph como cumplimiento parcial para el grado de doctor en ciencias veterinarias. Ontario:; 2013.Arias M, Egido J, Lamas S, Praga M, Séron D. Nefrología Clínica. 4th ed. Madrid: Medica Panamericana; 2014.Almy F. CM, King D. BS. Evaluation of cystatin c as an endogenous marke of glomerular filtration rate in dogs.. Journal of Veterinary Internal Medicine. 2002; 16.Ross L. Acute kidney injury in dogs and cats. Veterinary Clinics of North America: Small Animal Practice. 2011; 41.Ostermann M, Philips B, Forni L. Clinical review: biomarkers of acute kidney injury: where are we now. Critical Care. 2012; 16(233).De Geus H, Betjes M, Bakker J. Biomarkers for the prediction of acute kidney injury: a narrative review on current status and future challenges. Clinical Kidney Journal. 2012; 5.McDuffie JE, Gao J, Ma J, La D, Bittner A, Sonee M, et al. Novel genomic biomarkers for acute gentamicinnephrotoxicity in dog. Journal of Molecular and Integrative Physiology. 2013; 3.Bland SK, Cote O, Clark ME, DeLay J, Bienzie D. Characterization of kidney injury molecule-1 in cats. Journal of Veterinary Internal Medicine. 2014; 28.García MF, Coll E, Ventura S, Bermudo C, Cárdenas MC, Cortés M, et al. Cistatina c en evaluación de la función renal. Revista Laboratorio Clínico. 2011; 4(1).Ghys L, Paepe D, Smets P, Lefebvre H. DJ, Damiet S. Cystatin c: a new renal marker and its potential use in small animal medicine. Journal of veterinary Internal Medicine. 2014; 28.Wehner A, Hartmann K, Hirschberger J. Utility of serum cystatin c as a clinical measure of renal function in dogs. J Am Animal Hosp Assoc. 2008; 44(3).Miyagawa Y, Takemura N, Hirose H. Evaluation of the measurement of serum cystatin c by an enzyme-linked inmmunosorbent assay for humans as a marker of the glomerular filtration rate in dogs. J Vet Med Sci. 2009 septiembre; 71(76).Cobrin A, Blois SL, Kruth SA, Abrams-Ogg A CG, Dewey C. Biomarker in the assessment of acute and chronic diseases in the dog and cat. Journal of Small Animal Practice. 2013; 54.Knight E, Verhave J, Spiegelman D, Hillege H. Factors influencing serum cystatin c levels other than renal function and the impact on renal function measurement. Kidney International. 204; 65.De Loor J, Daminet S, Smets P, Maddens B, Meyer E. Urinary biomarkers for acute kidney injury in dogs. Journal of Veterinary Internal Medicine. 2013; 27.Nabity MB, Lees GE, Boggess MM, Yerramilli M, Obare E, Yerramili M, et al. Symmetric dimethylarginine assay validation, stability, and evaluation as a marker for the early dteection of chronic kidney disease in dogs. Journal of Veterinary Internal Medicine. 2015; 29(4).Raila J, Brunnberg L, Schweigert FJ, Kohn B. Influence of kidney function on urinary excretion of albumin and retinolbindig protein in dogs with naturally occurring renal disease. Am J Vet Res. 2010; 71.Hall JA, Yerramilli M, Obare E, Yerramilli M, Jewell DE. Comparison of serum concentrations of symmetric dimethylarginine and creatinine as kidney function biomarkers in cats with chronic kidney disease. Journal of Veterinary Internal Medicine. 2014; 28.Hall J, Yerramilli M, Obare E, Yerramilli M, Melendez L, Jewell D. Relationship between lean body mass and serum renal biomarkers in healthy dogs. Journal of Veterinary Internal Medicine. 2015 marzo; 29(3).Brian J, Obare E, Yerramilli M, Elliott J, Yerramilli M. Relationship between serum symmetric dimethylarginine concentrartion and glomerular filtration rate in cats. Journal of veterinary Internal Medicine. 2014; 28.Vinge L, Lees GE, Nielsen R, Kashtan CE, Bahr A. The effect of progressive glomerular disease on megalin-mediated endocytosis in kidney. Nephronl Dial Transplant. 2010; 25.Nabity MB, Lees GE, Cianciolo R, Boggess MM, Steiner JM, Suchodolski JS. Urinary biomarkers of renal disease in dogs with x-linked hereditary nephropathy. J Vet Intern Med. 2012; 26.Carrillo Esper R, Castillo Albarrán F, Pérez Jáuregui J. Lipocalina asociada con la gelatinasa de neutrófilos, un nuevo marcador de lesión renal aguda en el enfermo grave. Cirugía y Cirujanos. 2011; 79.Lee YJ, Hu YY, Lin YS, Chang CT, Lin FY, Wong ML, et al. Urine neutrophil gelatinase-associated lipocain (NGAL) as a biomarker for acute canine kidney injury. BMC Veterinary Research. 2012; 8.Steincbach S, Weis J, Schweighauser A, Francey T, Neiger R. Plasma and urine neutrophil gelatinase-associated lipocalin (NGAL) in dogs with acute kidney injury or chronic kidney. Journal of Veterinary Internal Medicine. 2014; 28.Seveg G, Palm C, LeRoy B, Cowgill LD, Westropp JL. Evaluation of neutrophil gelatinase-asscoated lipocalin as a marker of kidney injury in dogs. Journal of Veterinary Internal Medicine. 2013; 27.Bishop SA, Lucke VM, Stoke CR, Gruffydd-Jones TJ. Plasma and urine biochemical changes in cats with experimental inmune complex glomerulonephritis. Journal of Comparative Pathology. 1991; 104.Jepson RE, Brodbelt D, Vallance C, Syme HM, Elliot J. Evaluation of predictors of the development of azotemia in cats. Journal of Veterinary Internal Medicine. 2009; 23.Sparkes A, Caney S, Chalhoub S, Elliott J, Finch N, Gajanayake I, et al. ISFM Consensus Guidelines on the Diagnosis and Management of Feline Chronic Kidney Disease. Journal of Feline Medicine and Surgery. 2016; 18.Di Bartola SP. Renal Disease: Clinical Approach and Laboratory Evaluation. 6th ed. Ettinger SJ FE, editor. Saint Louis: Elsevier Saunders.; 2005.Watson AD, Lefebvre HP, Concordet D. Plasma exogenous creatinine clearance test in dogs: comparison with other methods and proposed limited sampling strategy. J Vet Inten Med. 2002; 16.Syme HM. Proteinuria in cats. Pronostic marker or mediator. J Feline Med Surg. 2009; 11.Lees GE, Jensen WA, Simpson DF. Persistent albuminuria precedes onset of overt proteinuria in male dogs with x-linked hereditary nephropathy. J Vet Intern Med. 2002; 16.Cotadellas O. Estadificación y Manejo de la enfermedad renal cronica. In Cortadella O, editor. Manual de nefrología y urología clínica canina y felina. Zaragoza: Grupo Asis Biomedia SL; 2012. p. 161-177.PublicationLICENSElicense.txtlicense.txttext/plain; charset=utf-84334https://repository.ucc.edu.co/bitstreams/0b276d68-917f-498d-98e1-bc22c0989665/download3bce4f7ab09dfc588f126e1e36e98a45MD53ORIGINAL2020_biomarcadores_moleculares_enfermedad.pdf2020_biomarcadores_moleculares_enfermedad.pdfapplication/pdf481467https://repository.ucc.edu.co/bitstreams/5b1e4bba-0b85-4c33-aea3-97924db13140/download065fb1b1d6400d4e5b9931233e592dd1MD512020_biomarcadores_moleculares_enfermedad-FormatoLicenciaUso.pdf2020_biomarcadores_moleculares_enfermedad-FormatoLicenciaUso.pdfapplication/pdf707251https://repository.ucc.edu.co/bitstreams/7c598537-c602-43d0-bbf0-501bbacbdeca/downloadc315274147b94cb8acd7446d5baedb59MD52THUMBNAIL2020_biomarcadores_moleculares_enfermedad.pdf.jpg2020_biomarcadores_moleculares_enfermedad.pdf.jpgGenerated Thumbnailimage/jpeg5103https://repository.ucc.edu.co/bitstreams/26b5e49f-1a4e-43a0-a8d0-32453444e655/download66638ed6ef7a876f7f555d368e9b0a31MD542020_biomarcadores_moleculares_enfermedad-FormatoLicenciaUso.pdf.jpg2020_biomarcadores_moleculares_enfermedad-FormatoLicenciaUso.pdf.jpgGenerated Thumbnailimage/jpeg4033https://repository.ucc.edu.co/bitstreams/abee456e-35fe-414c-9bb0-2479e957b84b/downloadfdc1794b698981c85bd540236fe3de90MD55TEXT2020_biomarcadores_moleculares_enfermedad.pdf.txt2020_biomarcadores_moleculares_enfermedad.pdf.txtExtracted texttext/plain45682https://repository.ucc.edu.co/bitstreams/5b25b125-3b06-4f6c-8033-c2a270d253db/download605dc0dabf68501b5058c5afa2d7b1dbMD562020_biomarcadores_moleculares_enfermedad-FormatoLicenciaUso.pdf.txt2020_biomarcadores_moleculares_enfermedad-FormatoLicenciaUso.pdf.txtExtracted texttext/plain75https://repository.ucc.edu.co/bitstreams/fdffd3f1-5c90-4ef8-a4b2-175f261d742f/downloadba6c6cdaf9a61e494cc62d8d1e4a5fe5MD5720.500.12494/16880oai:repository.ucc.edu.co:20.500.12494/168802024-08-09 12:31:38.139restrictedhttps://repository.ucc.edu.coRepositorio Institucional Universidad Cooperativa de Colombiabdigital@metabiblioteca.comVU5JVkVSU0lEQUQgQ09PUEVSQVRJVkEgREUgQ09MT01CSUEKUkVQT1NJVE9SSU9TIElOU1RJVFVDSU9OQUxFUwpMSUNFTkNJQSBERSBVU08KClBvciBtZWRpbyBkZWwgcHJlc2VudGUgZG9jdW1lbnRvLCBlbCBBdXRvcihlcyksIG1heW9yIChlcykgZGUgZWRhZCwgcXVpZW4gZW4gYWRlbGFudGUgc2UgZGVub21pbmFyw6EgZWwgQVVUT1IsIGNvbmZpZXJlIGEgbGEgVU5JVkVSU0lEQUQgQ09PUEVSQVRJVkEgREUgQ09MT01CSUEsIGNvbiBOSVQuIDg2MC0wMjk5MjQtNywgdW5hIExJQ0VOQ0lBIERFIFVTTyBkZSBvYnJhLCBiYWpvIGxhcyBzaWd1aWVudGVzIGNvbmRpY2lvbmVzLgoKQ0zDgVVTVUxBUwoKUFJJTUVSQS4gT2JqZXRvLiBFTCBBVVRPUiBwb3IgZXN0ZSBhY3RvIGF1dG9yaXphIGxhIHV0aWxpemFjacOzbiBkZSBsYSBvYnJhLCBkZSBjb25mb3JtaWRhZCBjb24gbG8gZXN0aXB1bGFkbyBhIGNvbnRpbnVhY2nDs246IAoKKGEpIFBhcmEgZWZlY3RvcyBkZSBsYSBwcmVzZW50ZSBsaWNlbmNpYSBzZSBhdXRvcml6YSBsYSByZXByb2R1Y2Npw7NuIGRlIGxhIG9icmEgYW50ZXJpb3JtZW50ZSBjaXRhZGEsIGxhIGN1YWwgc2UgYWxvamFyw6EgZW4gZm9ybWF0byBkaWdpdGFsIGVuIGxhcyBwbGF0YWZvcm1hcyBvIHJlcG9zaXRvcmlvcyBhZG1pbmlzdHJhZG9zIHBvciBsYSBVTklWRVJTSURBRCBvIGVuIG90cm8gdGlwbyBkZSByZXBvc2l0b3Jpb3MgZXh0ZXJub3MgbyBww6FnaW5hcyB3ZWIgZXNjb2dpZG9zIHBvciBsYSBVTklWRVJTSURBRCwgcGFyYSBmaW5lcyBkZSBkaWZ1c2nDs24geSBkaXZ1bGdhY2nDs24uIEFkaWNpb25hbG1lbnRlLCBzZSBhdXRvcml6YSBhIHF1ZSBsb3MgdXN1YXJpb3MgaW50ZXJub3MgeSBleHRlcm5vcyBkZSBkaWNoYXMgcGxhdGFmb3JtYXMgbyByZXBvc2l0b3Jpb3MgcmVwcm9kdXpjYW4gbyBkZXNjYXJndWVuIGxhIG9icmEsIHNpbiDDoW5pbW8gZGUgbHVjcm8sIHBhcmEgZmluZXMgcHJpdmFkb3MsIGVkdWNhdGl2b3MgbyBhY2Fkw6ltaWNvczsgc2llbXByZSB5IGN1YW5kbyBubyBzZSB2aW9sZW4gYWN1ZXJkb3MgY29uIGVkaXRvcmVzLCBwZXJpb2RvcyBkZSBlbWJhcmdvIG8gYWN1ZXJkb3MgZGUgY29uZmlkZW5jaWFsaWRhZCBxdWUgYXBsaXF1ZW4uCgooYikgU2UgYXV0b3JpemEgbGEgY29tdW5pY2FjacOzbiBww7pibGljYSB5IGxhIHB1ZXN0YSBhIGRpc3Bvc2ljacOzbiBkZSBsYSBvYnJhIG1lbmNpb25hZGEsIGVuIGFjY2VzbyBhYmllcnRvLCBwYXJhIHN1IHV0aWxpemFjacOzbiBlbiBsYXMgcGxhdGFmb3JtYXMgbyByZXBvc2l0b3Jpb3MgYWRtaW5pc3RyYWRvcyBwb3IgbGEgVU5JVkVSU0lEQUQuCgooYykgTG8gYW50ZXJpb3IgZXN0YXLDoSBzdWpldG8gYSBsYXMgZGVmaW5pY2lvbmVzIGNvbnRlbmlkYXMgZW4gbGEgRGVjaXNpw7NuIEFuZGluYSAzNTEgZGUgMTk5MyB5IGxhIExleSAyMyBkZSAxOTgyLgoKClNFR1VOREEuIE9yaWdpbmFsaWRhZCB5IHJlY2xhbWFjaW9uZXMuIEVsIEFVVE9SIGRlY2xhcmEgcXVlIGxhIE9CUkEgZXMgb3JpZ2luYWwgeSBxdWUgZXMgZGUgc3UgY3JlYWNpw7NuIGV4Y2x1c2l2YSwgbm8gZXhpc3RpZW5kbyBpbXBlZGltZW50byBkZSBjdWFscXVpZXIgbmF0dXJhbGV6YSAoZW1iYXJnb3MsIHVzbyBkZSBtYXRlcmlhbCBwcm90ZWdpZG8gcG9yIGRlcmVjaG9zIGRlIGF1dG9yKSBwYXJhIGxhIGNvbmNlc2nDs24gZGUgbG9zIGRlcmVjaG9zIHByZXZpc3RvcyBlbiBlc3RlIGFjdWVyZG8uIEVsIEFVVE9SIHJlc3BvbmRlcsOhIHBvciBjdWFscXVpZXIgYWNjacOzbiBkZSByZWl2aW5kaWNhY2nDs24sIHBsYWdpbyB1IG90cmEgY2xhc2UgZGUgcmVjbGFtYWNpw7NuIHF1ZSBhbCByZXNwZWN0byBwdWRpZXJhIHNvYnJldmVuaXIuCgpURVJDRVJBLiBDb250cmFwcmVzdGFjacOzbi4gRWwgQVVUT1IgYXV0b3JpemEgYSBxdWUgc3Ugb2JyYSBzZWEgdXRpbGl6YWRhIGRlIGNvbmZvcm1pZGFkIGNvbiBsYSBjbMOhdXN1bGEgUFJJTUVSQSBkZSBmb3JtYSBncmF0dWl0YSwgZXMgZGVjaXIsIHF1ZSBsYSB1dGlsaXphY2nDs24gZGUgbGEgbWlzbWEgbm8gZ2VuZXJhIG5pbmfDum4gcGFnbyBvIHJlZ2Fsw61hcyBlbiBmYXZvciBkZSBlc3RlLgoKQ1VBUlRBLiBUaXR1bGFyaWRhZCBkZSBkZXJlY2hvcy4gRWwgcHJlc2VudGUgY29udHJhdG8gbm8gdHJhbnNmaWVyZSBsYSB0aXR1bGFyaWRhZCBkZSBsb3MgZGVyZWNob3MgcGF0cmltb25pYWxlcyBzb2JyZSBsYXMgb2JyYXMgYW50ZXJpb3JtZW50ZSBtZW5jaW9uYWRhcyBhIGxhIFVOSVZFUlNJREFELiDDmm5pY2FtZW50ZSBoYWNlIHJlbGFjacOzbiBhIHVuYSBsaWNlbmNpYSBubyBleGNsdXNpdmEgZW4gbG9zIHTDqXJtaW5vcyB5IGNvbmRpY2lvbmVzIGFudGVyaW9ybWVudGUgcGFjdGFkb3MuCgpRVUlOVEEuIENyw6lkaXRvcy4gTGEgVU5JVkVSU0lEQUQgc2UgY29tcHJvbWV0ZSBhIGRhciBhbCBBVVRPUiwgZWwgcmVjb25vY2ltaWVudG8gZGVudHJvIGNhZGEgZm9ybWEgZGUgdXRpbGl6YWNpw7NuIGVuIGxhIG9icmEuIExvcyBjcsOpZGl0b3MgZGViZW4gZmlndXJhciBlbiBjYWRhIHVubyBkZSBsb3MgZm9ybWF0b3MgbyByZWdpc3Ryb3MgZGUgcHVibGljYWNpw7NuLiBObyBjb25zdGl0dWlyw6EgdW5hIHZpb2xhY2nDs24gYSBsb3MgZGVyZWNob3MgbW9yYWxlcyBkZWwgYXV0b3IgbGEgbm8gcmVwcm9kdWNjacOzbiwgY29tdW5pY2FjacOzbiBvIGRlbcOhcyB1dGlsaXphY2lvbmVzIGRlIGxhIG9icmEuIExhIHV0aWxpemFjacOzbiBvIG5vIGRlIGxhIG9icmEsIGFzw60gY29tbyBzdSBmb3JtYSBkZSB1dGlsaXphY2nDs24gc2Vyw6EgZmFjdWx0YWQgZXhjbHVzaXZhIGRlIGxhIFVOSVZFUlNJREFELgogClNFWFRBLiBEdXJhY2nDs24geSB0ZXJyaXRvcmlvLiBMYSBwcmVzZW50ZSBsaWNlbmNpYSBkZSB1c28gcXVlIHNlIG90b3JnYSBhIGZhdm9yIGRlIGxhIFVOSVZFUlNJREFEIHRlbmRyw6EgdW5hIGR1cmFjacOzbiBlcXVpdmFsZW50ZSBhbCB0w6lybWlubyBkZSBwcm90ZWNjacOzbiBsZWdhbCBkZSBsYSBvYnJhIHkgcGFyYSB0b2RvcyBsb3MgcGHDrXNlcyBkZWwgbXVuZG8uCgpTw4lQVElNQS4gVXNvIGRlIENyZWF0aXZlIENvbW1vbnMuIEVsIEFVVE9SIGF1dG9yaXphcsOhIGxhIGRpZnVzacOzbiBkZSBzdSBjb250ZW5pZG8gYmFqbyB1bmEgbGljZW5jaWEgQ3JlYXRpdmUgQ29tbW9ucyBhdHJpYnVjacOzbiA0LjAgaW50ZXJuYWNpb25hbCwgcXVlIGRlYmVyw6EgaW5jbHVpcnNlIGVuIGVsIGNvbnRlbmlkby4gCgpPQ1RBVkEuIERlcmVjaG8gZGUgZXhjbHVzacOzbi4gQ2FkYSBhdXRvciBwdWVkZSBpbmRpY2FyIGVuIGVsIG1vbWVudG8gZGUgZGVww7NzaXRvIGRlbCBjb250ZW5pZG8gcXVlIGVsIHRleHRvIGNvbXBsZXRvIGRlIGxhIHByb2R1Y2Npw7NuIGFjYWTDqW1pY2EgbyBjaWVudMOtZmljYSBubyBlc3RlIGNvbiBhY2Nlc28gYWJpZXJ0byBlbiBlbCBSZXBvc2l0b3JpbyBJbnN0aXR1Y2lvbmFsIHBvciBtb3Rpdm9zIGRlIGNvbmZpZGVuY2lhbGlkYWQsIHBvcnF1ZSBzZSBlbmN1ZW50cmUgZW4gdsOtYXMgZGUgb2J0ZW5lciB1biBkZXJlY2hvIGRlIHByb3BpZWRhZCBpbmR1c3RyaWFsIG8gZXhpc3RpciBhY3VlcmRvcyBwcmV2aW9zIGNvbiB0ZXJjZXJvcyAoZWRpdG9yaWFsZXMsIHJldmlzdGFzIGNpZW50w61maWNhcywgb3RyYXMgaW5zdGl0dWNpb25lcykuIEVsIGF1dG9yIHNlIGNvbXByb21ldGUgYSBkZXBvc2l0YXIgbG9zIG1ldGFkYXRvcyBlIGluZm9ybWFyIGVsIHRpZW1wbyBkZSBlbWJhcmdvIGR1cmFudGUgZWwgY3VhbCBlbCB0ZXh0byBjb21wbGV0byB0ZW5kcsOhIGFjY2VzbyByZXN0cmluZ2lkby4gCgpOT1ZFTkEuIEVsIEFVVE9SIGFsIGFjZXB0YXIgZXN0YSBsaWNlbmNpYSBhZHVjZSBxdWUgZXN0YSBwcm9kdWNjacOzbiBzZSBkZXNhcnJvbGzDsyBlbiBlbCBwZXJpb2RvIGVuIHF1ZSBzZSBlbmN1ZW50cmEgY29uIHbDrW5jdWxvcyBjb24gTGEgVW5pdmVyc2lkYWQuCgpEw4lDSU1BLiBOb3JtYXMgYXBsaWNhYmxlcy4gUGFyYSBsYSBpbnRlcnByZXRhY2nDs24geSBjdW1wbGltaWVudG8gZGVsIHByZXNlbnRlIGFjdWVyZG8gbGFzIHBhcnRlcyBzZSBzb21ldGVuIGEgbGEgRGVjaXNpw7NuIEFuZGluYSAzNTEgZGUgMTk5MywgbGEgTGV5IDIzIGRlIDE5ODIgeSBkZW3DoXMgbm9ybWFzIGFwbGljYWJsZXMgZGUgQ29sb21iaWEuIEFkZW3DoXMsIGEgbGFzIG5vcm1hcyBJbnN0aXR1Y2lvbmFsZXMgcXVlIGFwbGlxdWVuLgoKTGEgcHJlc2VudGUgbGljZW5jaWEgc2UgYXV0b3JpemEgZW4gbGEgZmVjaGEgZGUgcHVibGljYWNpw7NuIGVuIGxvcyByZXBvc2l0b3Jpb3MgaW5zdGl0dWNpb25hbGVzLgo=

Biomarcadores moleculares en enfermedad renal aguda para determinar porcentaje de daño en el parenquima: revisión bibliográfica

Publicaciones similares